New Haven, CT – According to filings with the U.S. Securities and Exchange Commission, AtlasXomics is raising $8,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kenneth Wang played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AtlasXomics
AtlasXomics, a 2020 Yale spin out, is commercializing a novel discovery platform that provides clinicians and researchers with unprecedented multi omics tissue atlases. This innovative platform, called Deterministic Barcoding in Tissue for spatial omics sequencing (DBiT seq), was developed by Dr. Rong Fan, Professor of Biomedical Engineering at Yale University. DBiT seq leverages microfluidics and next generation sequencing (NGS) to create transformative multi omic maps (proteomics, transcriptomics, and epigenomics) in tissue at cellular resolution, unlocking information about interactions between cells in localized neighborhoods. The platform was published in Cell in 2020. DBiT seq is the first platform to offer spatial ATAC seq and spatial CUT & Tag for mapping chromatin accessibility and histone modifications across the entire genome in tissue.

To learn more about AtlasXomics, visit http://www.atlasxomics.com/

Contact:
Kenneth Wang, Chief Executive Officer
917-841-1327

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved